MEGHAN SLOAN: Open Payments
NPI 1780257592 · MASSAPEQUA PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 38 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $305 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $226 |
| Indivior Inc. | 5 | $126 |
| Alkermes, Inc. | 5 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| Braeburn Inc. | 4 | $94 |
| ABBVIE INC. | 5 | $91 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
| Orexo US, Inc. | 1 | $18 |
Products named: CAPLYTA, SUBLOCADE, VIVITROL, INGREZZA, BRIXADI, MAVYRET, ABILIFY ASIMTUFII, REXULTI.
Industry payments across NY — which companies pay providers there.
